Clinical trial
A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta…
NCT00090753 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00090753 |
|---|---|
| Title | A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia |
| Official title | An Open-label, Multi-center Study to Document the Efficacy, Safety, and Tolerability of Long-term Administration of RO0503821 in Patients With Chronic Renal Anemia |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Methoxy Polyethylene Glycol-Epoetin Beta, Epoetin alfa, Epoetin beta, Darbepoetin alfa |
| Enrollment | 1,228 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 6, 2004 |
| Last update posted | Feb 14, 2012 |
| Countries | Australia, Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Mexico and 15 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: